Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
SLAM family member 6 (SLAMF6) is a single-pass transmembrane glycoprotein encoded by the SLAMF6 gene, featuring two extracellular immunoglobulin domains, a transmembrane helix and cytoplasmic immunoreceptor tyrosine-based switch motif tail, functioning as homotypic recognition subunit of SLAM lymphocyte receptor complexes. SLAMF6 is broadly expressed across T lymphocytes, B lymphocytes and myeloid immune cell subsets, acting as central scaffold to drive homotypic cell adhesion and recruit downstream adaptive immune kinases upon intercellular receptor matching.
SLAMF6 executes biological functions via homotypic trans-assembly between adjacent immune cell surfaces, a mechanism stabilizing intercellular immune synapses and tuning intracellular adaptive immune cascade efficiency. Distinct from ligand-specific immune receptors, SLAMF6 cannot trigger full immune signals without matching homotypic counterparts and depends on intercellular dimerization for complete signal output; it recruits cytoplasmic signal mediators to synaptic receptor assemblies, separating intercellular recognition events from nuclear immune transcription factor activation and sustaining long-term adaptive immune responses. This dual regulatory mode modulates the magnitude of lymphocyte cross-talk after intercellular contact, fine-tunes lymphocyte proliferation and immune mediator secretion levels, while persistent aberrant SLAMF6 signal transmission induces overactive autoreactive lymphocyte lesions. SLAMF6 participates in core physiological and pathological events covering adaptive immune synapse formation, lymphocyte co-stimulation, autoreactive cell expansion and chronic autoimmune disorders. Abnormal SLAMF6 expression or homotypic binding capacity correlates strongly with disrupted immune self-tolerance and aggravated autoimmune tissue damage, making SLAMF6 a vital research target for SLAM receptor signaling, adaptive immunity and autoimmune disease exploration.
Fig. 1 Transcriptomic enrichment and proteomic interactome analysis of SLAMF6-mediated TCR co-stimulatory signaling in T cells.1
The biological functions of SLAMF6 are focused on SLAM homotypic receptor dimerization, adaptive immune signal propagation and lymphoid self-tissue balance:
Creative Biolabs offers high-purity SLAMF6 proteins via optimized heterologous expression platforms, including full-length constructs and isolated extracellular Ig domain variants with modified glycosylation profiles. These products retain native structural conformation and homotypic intercellular binding capacity, suitable for SLAM immune synapse research, intercellular receptor complex detection and small molecule autoimmune modulator screening. All SLAMF6 proteins pass strict quality inspections covering purity testing and biological functional verification to guarantee intact activity.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom SLAMF6 stable cell models with overexpression and knockdown phenotypes in lymphoid and myeloid cell backgrounds. These cell lines are optimized for research on SLAM homotypic assembly mechanisms, lymphocyte co-stimulatory signal cascades and autoimmune compound responsiveness. Each model undergoes strict validation of stable expression and complete biological functionality.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-affinity recombinant antibodies targeting SLAMF6 are generated through advanced antibody engineering workflows, without cross-reactivity against other SLAM family receptor subunits. These reagents are validated for immunofluorescence membrane localization detection, Western blot expression profiling and co-immunoprecipitation of intercellular SLAM complexes, enabling precise analysis of SLAMF6 expression, subcellular localization and functional regulation.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for SLAMF6 research:
SLAMF6 is a homotypic SLAM receptor forming trans-cellular dimers to regulate T-B lymphocyte co-stimulatory signal intensity, maintain lymphoid immune self-tolerance and control autoreactive lymphocyte expansion upon intercellular immune contact.
SLAMF6 acts as a core controller of immune synapse assembly and adaptive self-tolerance; its dysregulation triggers autoreactive lymphoproliferative lesions, making it an essential research object for SLAM signaling and autoimmune diseases.
No, all SLAMF6 products and related services are solely intended for laboratory research, not applicable to clinical diagnosis or therapeutic administration.
The portfolio includes full-length and truncated extracellular SLAMF6 proteins, specific recombinant antibodies, and custom stable lymphoid cell lines supporting SLAM synapse and autoimmune research.
SLAMF6 proteins are tested via homotypic intercellular binding assays and co-stimulatory signal functional verification to retain native regulatory function in lymphocyte research.
